Suraksha Diagnostic Limited
₹305.00▼ -2.65 (-0.86%)
SURAKSHA·NSE·Healthcare
Market Cap
1596.80 Cr
PE Ratio
49.35
Volume
23,055
Day High - Low
325.00 - 304.15
52W High-Low
360.00 - 224.10
₹305.00▼ -2.65 (-0.86%)
Market Cap1596.80 Cr
PE Ratio49.35
Volume23,055
Day High - Low325.00 - 304.15
52W High-Low360.00 - 224.10
Suraksha Diagnostic Limited (SURAKSHA): company summary
The company's revenue grew 23.2% annually, with the latest quarter showing a 20.7% increase compared to the same quarter a year earlier.
Suraksha Diagnostic Limited (SURAKSHA) is a micro-cap Healthcare company valued at ₹1,597 crore operating in Healthcare Service Provider on the NSE and BSE.
- Recent price move
- Suraksha Diagnostic Limited last traded at ₹305, modestly down 0.86% on the day.
- Recent developments
- On 2026-09-15, the company announced a dividend of ₹0.50 per share, effective from that date. Promoter holding remained at 49.10% as of 2026-09-30, with 0.10% of shares pledged. Foreign institutional holding increased by 0.50 points in the quarter, while domestic institutional holding decreased by 1.67 points.
- Financial performance
- The company's revenue grew 23.2% annually, with the latest quarter showing a 20.7% increase compared to the same quarter a year earlier. Net profit rose 1.3% annually but narrowed to 10.1% of revenue, down 2.2 percentage points from the prior year. Profit in the latest quarter surged 40.0% compared to the same quarter a year ago, outpacing revenue growth.
- Valuation multiples
- The stock trades at 49.4 times earnings, a premium to the Healthcare median of 32.0, 6.97 times book value. It yields 0.1%.
- Things to watch
- The net profit margin narrowed by 2.2 percentage points to 10.1%, indicating pressure on profitability. The stock is 14.8% below its 52-week high, and domestic institutional holding fell by 1.67 points in the quarter. Promoter shares pledged amount to 0.10% of their holding.
- Where it stands
- Suraksha Diagnostic Limited reported annual revenue growth of 23.2% and net profit growth of 1.3%, with the latest quarter showing strong profit growth of 40.0% compared to the same quarter a year earlier. The stock is 14.8% below its 52-week high, and the net profit margin narrowed to 10.1%. The company's return on equity stands at 13.1%, and debt to equity is 0.53.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.6/10
Fair
Fair Value
Sign in to see
ROE
13.15%
Average
P/E
49.35x
Expensive
Debt / Equity
0.53
Moderate
Industry
Healthcare
Healthcare Service Provider
Overall View
Mixed
Price performance
Day₹304.15
₹325.00
52W₹224.10
₹360.00
DocStoX take
Supported by risk (7.8) and growth (7.7), but held back by valuation (0.0). Risk looks strong at 7.8, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence5.6
/10
Fair
Quality
Solid
ROE 13.1%
Valuation
Expensive
P/E 49.4×
Growth
Strong
Revenue +17.3% 5Y CAGR
Risk
Low risk
D/E 0.53
Momentum
Firm
60% of 52-week range
At a glance
Market Cap
₹1,597 Cr
52W High / Low
₹360 / ₹224
Dividend Yield
0.15%
Promoter Holding
49.10%
EPS (TTM)
₹6.18
Book Value
₹47.01
Key highlights
- Profit compounding 39% a year
- Profitable in all of the last 5 years
- Revenue compounding 17% a year
- Valuation is weak (0.0/10)
3 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Healthcare Service Provider
Explore Suraksha Diagnostic Limited’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Suraksha Diagnostic Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Suraksha Diagnostic Limited with peers
Suraksha Diagnostic Limited vs Sun Pharmaceutical Industries LimitedSuraksha Diagnostic Limited vs Divi's Laboratories LimitedSuraksha Diagnostic Limited vs Torrent Pharmaceuticals LimitedSuraksha Diagnostic Limited vs Apollo Hospitals Enterprise LimitedSuraksha Diagnostic Limited vs Zydus Lifesciences LimitedSuraksha Diagnostic Limited vs Laurus Labs Limited
Related tools & concepts
Value Suraksha Diagnostic Limited with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing